Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 12, 2016

Interference by biological anti-cancer drugs in electrophoretic and immunofixation techniques

Giovanni Cigliana, Gaia Illuminati, Elena De Santis, Laura Conti, Francesco Pisani, Antonella La Malfa, Ermanno Longhi, Ornella Gottardi, Mario D’Ambrosio, Silvia Gelsumini and Arialdo Vernocchi

Corresponding author: Giovanni Cigliana, Clinical Pathology, National Cancer Institute “Regina Elena”, Via Elio Chianesi 53, 00144 Rome, Italy, Phone: +390652666935, Fax: +390652665261, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ruinemans-Koerts J, Verkroost C, Schmidt-Hieltjes Y, Wiegers C, Curvers J, Thelen M, et al. Interference of therapeutic monoclonal immunoglobulins in the investigation of M-protein. Clin Chem Lab Med 2014;52:235–7.10.1515/cclm-2013-0898Search in Google Scholar PubMed

2. Rabing-Brix-Peterson E, Sørensen PD, Jakobsen EH, Skov Madsen J, Brandslund I. Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer. Clin Chem Lab Med 2013;51:1483–92.Search in Google Scholar

3. Jonathan R, Genzen JR, Kawaguchi KR, Furman RR. Detection of a monoclonal antibody therapy (ofatumumab) by serum protein and immunofixation electrophoresis. Br J Haematol 2011;155:122–32.Search in Google Scholar

4. McCudden CR, Voorhees PM, Hainsworth SA, Whinna HC, Chapman JF, Hammett-Stabler CA, et al. Interference of Monoclonal Antibody Therapies with serum protein electrophoresis tests. Clin Chem 2010;56:1897–904.10.1373/clinchem.2010.152116Search in Google Scholar PubMed

5. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary Breast Cancer ESMO clinical practice guidelines. Ann Oncol 2015;26(Suppl 5):v8–30.10.1093/annonc/mdv298Search in Google Scholar PubMed

6. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic Colorectal Cancer ESMO clinical practice guidelines. Ann Oncol 2014;25(Suppl 3):iii1–9.10.1093/annonc/mdu260Search in Google Scholar PubMed

7. Tate J, Caldwell G, Daly J, Gillis D, Jenkins M, Jovanovich S, et al. on behalf of the Working Party on Standardised Reporting of Protein Electrophoresis. Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand. Ann Clin Bioch 2012;49:242–56.10.1258/acb.2011.011158Search in Google Scholar PubMed

Received: 2015-11-5
Accepted: 2016-2-1
Published Online: 2016-3-12
Published in Print: 2016-10-1

©2016 Walter de Gruyter GmbH, Berlin/Boston